RN5681
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RN5681, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1a Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RN5681 in Healthy Volunteers [Phase 1]